Wednesday, November 1, 2006 6:00:00 AM PDT | VentureDeal Staff
REDMOND, WA -- Endovascular treatment designer Pathway Medical Technologies has announced the closing of a $25 million Series B round of financing. Two new investors joined the round as did existing investors. The company is developing what it calls a Pathway Atherectomy System that treats patients diagnosed with Peripheral Arterial Disease (PAD). The company is still in early clinical stage and will likely use the funds to advance its product through additional clinical trials.
Email Page | Print Page
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
